On Feb. 20, 2019, Weekend Unlimited Inc. (CSE: POT) (FSE: 0OS1) (OTCMKTS: WKULF) completed its previously announced arms-length acquisition of R&D Pharma Corp.

R&D Pharma is a Canadian company building a vertically integrated medical cannabis business in Jamaica. The company has secured a Tier 3 Cultivator's License (only one of three presently issued in the country), which allows for full cultivation of cannabis plants on land of over 5 acres.

On Feb. 7, 2019, US-based Foundation Building Materials, Inc. (NYSE: FBM) announced its cross-border acquisition of Builders' Supplies Limited of Mississauga, Ontario.

Builders' Supplies is a key distributor of industrial and commercial building materials in the Greater Toronto market with yards in Mississauga, Brampton, Scarborough and Cambridge, Ontario.

TLT has advised the shareholders of Manchester-based creative agency BJL on the acquisition of the business by Dentsu Aegis Network.

The deal, for an undisclosed amount, saw TLT advise BJL’s CEO Nicky Unsworth, Managing Partner Jackie Holt and Commercial Director Iain Kerr, who all completed a management buyout of the agency in 2004. The trio will remain in their roles and will continue to lead BJL following the deal.

Orrick advised independent mid-market private equity fund Findos Investor on the sale of its majority stake in auto parts retailer Rameder Group to FSN Capital.

Findos Investor is a Munich-based independent mid-market private equity fund backed exclusively by prestigious German family-owned companies as investors. It invests in medium-sized companies with a turnover of €25-200 million, growth potential, an established market position, and independent management.

Gide has advised Societe Generale group on closing the sale of the entire stake of Boursorama in Self Trade Bank S.A.U., its Spanish subsidiary, to private equity fund Warburg Pincus.

The sale was announced in June 2018.

This transaction is part of Societe Generale group's continuous effort to simplify its setup and to focus on its core businesses to create synergies within the group.

CMS has acted for Delancey-advised fund, DV4 Limited, and management on the sale of its investment in db Symmetry (dbS) to Tritax Big Box REIT plc (Tritax). The deal values dbS at £370m with the consideration being settled in cash and shares. Completion of the sale was conditional upon FTSE 250-listed Tritax successfully completing a placing and open offer to raise acquisition funds.